These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4933788)

  • 1. [Influence of aluminum nicotinate on serum lipids].
    Harvengt C; Lavenne F
    Acta Cardiol; 1969; 24(6):543-57. PubMed ID: 4933788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of oxandrolone on the serum lipids in type IV and IIb hyperlipidemia].
    Zorrilla E; Magos C; Serrano PA
    Arch Inst Cardiol Mex; 1973; 43(2):270-8. PubMed ID: 4712792
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of SU-13437 on serum lipids in hyperlipoproteinemic patients.
    Weiss P; Dujovne CA; Margolis S; Lasagna L; Bianchine JR
    Clin Pharmacol Ther; 1970; 11(1):90-6. PubMed ID: 4903694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
    Orö L
    Lakartidningen; 1970 Dec; 67():Suppl IV:63+. PubMed ID: 5511953
    [No Abstract]   [Full Text] [Related]  

  • 7. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 8. A long-term study of the efficacy of oxandrolone in hyperlipoproteinemias.
    Malmendier CL; van den Bergen CJ; Emplit G; Delcroix C
    J Clin Pharmacol; 1978 Jan; 18(1):42-53. PubMed ID: 338645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of triglyceridemia, lipemia, glycemia and weight index in patients with high and normal serum uric acid].
    Kuntz D; Rouques C; Paolaggi F; Ryckewaert A
    Pathol Biol (Paris); 1969 Apr; 17(7):399-403. PubMed ID: 4893908
    [No Abstract]   [Full Text] [Related]  

  • 11. Mefenamic acid compared with indomethacin and placebo in osteoarthritis.
    Buchmann E
    Ann Phys Med; 1966; Suppl():119-25. PubMed ID: 4895004
    [No Abstract]   [Full Text] [Related]  

  • 12. The uricosuric action of halofenate (MK-185) in patients with hyperuricemia or uncomplicated primary gout and hyperlipidemia.
    Hutchison JC; Wilkinson WH
    Atherosclerosis; 1973; 18(3):353-62. PubMed ID: 4584481
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arteriosclerosis--nicotinic acid therapy. 6. Treatment of hyperlipemia].
    Orö L
    Lakartidningen; 1971 Apr; 68(15):1758-62. PubMed ID: 5577248
    [No Abstract]   [Full Text] [Related]  

  • 14. [Senile macular degeneration and disorders of lipid metabolism].
    Scouras J; Netter G
    Ophthalmologica; 1973; 166(6):450-9. PubMed ID: 4127374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris].
    Dubiel W; Happle R
    Z Haut Geschlechtskr; 1972 Jul; 47(13):545-50. PubMed ID: 4265800
    [No Abstract]   [Full Text] [Related]  

  • 16. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of Etilefrin on clinico-chemical findings].
    Husmann F
    MMW Munch Med Wochenschr; 1974 Sep; 116(39):1687-8. PubMed ID: 4216777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 20. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.